Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Journal of Affective Disorders, 2023
Dissecting the causal association between inflammation and post-traumatic stress disorder: A bidirectional Mendelian randomization study

Zuo C., Zhuang Z., Yang P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Cardiovascular Research, 2023
Arterial wall inflammation assessed by 18F-FDG-PET/CT is higher in individuals with Type 1 diabetes and associated with circulating inflammatory proteins

Janssen A., van Heck J., Stienstra R. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

JCI Insight, 2023
High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV

Vadaq N., Zhang Y., Vos W. et al.

Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma

Computational and Structural Biotechnology Journal, 2023
Network-based drug repurposing for potential stroke therapy

Wu Q., Chen C., Liu W. et al.

Olink Target 96CVDNeurologyPathophysiologyCell Culture Lysate

International Journal of Molecular Sciences, 2023
Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling

Sîrbe C., Badii M., Crişan T. et al.

Olink Target 96Immunological & Inflammatory DiseasesHepatologyPatient StratificationSerum

Intensive Care Medicine, 2023
Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

Roquilly A., Francois B., Huet O. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationSerum

International Journal of Molecular Sciences, 2023
Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study

Mesleh A., Ehtewish H., de la Fuente A. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationSerum

Oxford Open Immunology, 2023
Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance

Rodriguez L., Pou C., Lakshmikanth T. et al.

Olink Target 96NeurologyPathophysiologyPlasma

European Journal of Heart Failure, 2023
A machine learning‐derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: Findings from the HOMAGE trial

Kobayashi M., Huttin O., Ferreira J. et al.

Olink Target 96CVDPatient Stratification

Clinical and Experimental Medicine, 2023
Unique immune and inflammatory cytokine profiles may define long COVID syndrome

Allan-Blitz L., Akbari O., Kojima N. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Journal of Cachexia, Sarcopenia and Muscle, 2023
Direct electrical stimulation impacts on neuromuscular junction morphology on both stimulated and unstimulated contralateral soleus

Lee Y., Cacciani N., Wen Y. et al.

Olink Target 96 MouseNeurologyPathophysiologyPlasmaTissue Lysate

Gastroenterology, 2023
Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study

Lee B., Jones E., Manohar M. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

British Journal of Dermatology, 2023
Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis

Quaade A., Wang X., Sølberg J. et al.

Olink Target 96Dermatological DiseasesPathophysiologyPlasma

International Journal of Molecular Sciences, 2023
Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies

Liu H., Santos L., Smith S.

Olink Target 96Dermatological DiseasesPathophysiologySerum

Nature Medicine, 2023
Body composition and lung cancer-associated cachexia in TRACERx

Al-Sawaf O., Weiss J., Skrzypski M. et al.

Olink Explore 3072/384OncologyMetabolic DiseasesPathophysiologyPlasma

Journal of Immunological Methods, 2023
Comparison of multiplexed protein analysis platforms for the detection of biomarkers in the nasal epithelial lining fluid of healthy subjects

Zetlen H., Cao K., Schichlein K. et al.

Olink Target 96Wider Proteomics StudiesTechnical EvaluationNasal Fluid

Journal of Leukocyte Biology, 2023
Immune profiling in Puerto Rican injection drug users with and without HIV-1 infection

Bennett S., Davila C., Reyes Z. et al.

Infectious DiseasesPathophysiology

The Lancet Regional Health - Europe, 2023
Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial

Dulfer E., Geckin B., Taks E. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Journal of the American Academy of Dermatology, 2023
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin

Kim M., Del Duca E., Cheng J. et al.

Dermatological DiseasesPathophysiologySkin Punch Biopsy Lysate

Allergy, 2023
Age of onset defines two distinct profiles of atopic dermatitis in adults

Facheris P., Da Rosa J., Pagan A. et al.

Olink Target 96Dermatological DiseasesPatient StratificationPlasma

1945 publications